Home / Recalls / PD-Rx Pharmaceuticals, Inc. / D-1276-2020

D-1276-2020 Class II Terminated

Recalled by PD-Rx Pharmaceuticals, Inc. — Oklahoma City, OK

Recall Details

Product Type
Drugs
Report Date
June 3, 2020
Initiation Date
May 15, 2020
Termination Date
November 8, 2021
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
14,030 bottles

Product Description

Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b) 10-count (NDC 55289-866-10), c) 14-count (NDC 55289-866-14), d) 20-count (NDC 55289-866-20), e) 28-count (NDC 55289-866-28), f) 30-count (NDC 55289-866-30), g) 60-count (NDC 55289-866-60), h) 120-count (NDC 55289-866-98), i) 210-count (NDC 55289-866-71), j) 300-count (NDC 55289-866-87), k) 400-count (NDC 55289-866-74), Rx only, PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127

Reason for Recall

Failed dissolution specifications

Distribution Pattern

USA Nationwide

Code Information

Lots: a) L18B72, Exp 12/31/2020; b)I18B83, Exp 06/30/2020 ; c) H18B11, Exp 06/30/2020; I18A53, Exp 06/30/2020; J18F97, Exp 10/31/2020; K18A33, Exp 11/30/2020; K18D17, Exp 11/30/2020; L18A11, Exp 12/31/2020; L18A29, Exp 12/31/2020; L18D81, Exp 12/31/2020; d) H18F60, Exp 06/30/2020; I18C26, Exp 06/30/2020; I18D61, Exp. 06/30/2020; J18B80, Exp 10/31/2020; K18C97 Exp 11/30/2020; L18B30, Exp. 12/31/2020; L18D25, Exp 12/31/2020; L18E50 Exp 12/31/2020; e) I18D07, Exp. 06/30/2020; J1E02, Exp 10/31/2020; J18E62 Exp 10/31/2020; K18E98 Exp. 11/30/2020; L18C54, Exp 12/31/2020; f) H18E18 Exp. 06/30/2020, I18F94 Exp. 09/30/2020, J18E42, Exp. 10/31/2020, L18B56 Exp. 12/31/2020; g) J18C84 Exp. 10/31/2020, A19B70 Exp. 01/31/2021; h) K18E92 Exp. 11/30/2020; i) I18E80 Exp. 06/30/2020, K18A19 Exp. 11/30/2020; j) F18E11 Exp. 06/30/2020, G18E66 Exp. 06/30/2020, H18E72 Exp. 06/30/2020, I18E75 Exp. 09/30/2020, I18E95 Exp. 09/30/2020, I18F64 Exp. 09/30/2020; k) A19D44 Exp. 08/31/2020, H18E76 Exp. 06/30/2020, I18F21 Exp. 09/30/2020, L18B91 Exp. 12/31/2020

Other recalls by PD-Rx Pharmaceuticals, Inc.

  • D-0163-2025 Class II — DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharmaceu (December 4, 2024)
  • D-0560-2023 Class II — Simvastatin USP 20 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg (April 6, 2023)
  • D-0559-2023 Class II — Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: P (April 6, 2023)
  • D-0558-2023 Class II — Simvastatin USP, 10 mg, Rx only, Intas Pharm, Limited Ahmedabad 380 054 India Pk (April 6, 2023)
  • D-0561-2023 Class II — Simvastatin USP 40 mg, Rx only, Intas Pharm. Limited Ahmedabad 380 054 India Pkg (April 6, 2023)
  • D-0557-2023 Class II — Montelukast Sodium USP, 10 mg, 30 count-bottles, Rx only, Intas Pharm, Limited A (April 6, 2023)
  • D-1161-2022 Class II — Losartan Potassium Tablets, USP 25 mg, 90 Tablets bottles, Rx Only Marketed and (June 6, 2022)
  • D-1162-2022 Class II — Losartan Potassium Tablets, USP 50 mg, 90 Tablets bottles, Rx Only Marketed and (June 6, 2022)
  • D-1163-2022 Class II — Losartan Potassium Tablets, USP 100 mg, 90 Tablets bottles, Rx Only, Marketed an (June 6, 2022)
  • D-0060-2021 Class II — metformin HCL ER 750 mg Rx only Pkg By: PD-Rx Pharmaceuticals Incorporated Oklah (October 6, 2020)